Literature DB >> 29771754

Orbital Decompression for Thyroid-Related Orbitopathy During the Quiescent Phase.

Lilangi S Ediriwickrema1, Bobby S Korn1,2, Don O Kikkawa1,2.   

Abstract

PURPOSE: To describe historical and modern surgical approaches to orbital decompression in patients with thyroid-related orbitopathy in the quiescent phase.
METHODS: A literature review of published techniques using the National Institutes of Health PubMed database.
RESULTS: Historically, orbital decompression has been accomplished via transantral, transcranial, transnasal, and orbital approaches. Current techniques use predominately periocular incisions to achieve effective decompression and proptosis reduction. Based on exophthalmometry and desired proptosis reduction, the authors propose a graded surgical approach to decompression for thyroid orbitopathy beginning with fat reduction, followed by deep lateral orbit via a superior eyelid crease incision, then medial wall by retro-caruncular approach, then posterior medial orbital floor either via transconjunctival or swinging eyelid approach, and finally with lateral orbital rim removal by superior eyelid crease incision as needed. These approaches can result in a range of proptosis reduction of up to 10 mm.
CONCLUSIONS: A structured approach to orbital decompression results in predictable and effective outcomes in proptosis reduction.

Entities:  

Mesh:

Year:  2018        PMID: 29771754     DOI: 10.1097/IOP.0000000000001119

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  5 in total

1.  Computed Tomography-Based Prediction of Exophthalmos Reduction After Deep Lateral Orbital Wall Decompression for Graves' Orbitopathy.

Authors:  Yoshiyuki Kitaguchi; Yasuhiro Takahashi; Hirohiko Kakizaki
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-10-23       Impact factor: 3.117

2.  MicroRNA-27 inhibits adipogenic differentiation in orbital fibroblasts from patients with Graves' orbitopathy.

Authors:  Sun Young Jang; Min Kyung Chae; Joon H Lee; Eun Jig Lee; Jin Sook Yoon
Journal:  PLoS One       Date:  2019-08-15       Impact factor: 3.240

3.  Change of intraocular blood flow during treatment for thyroid eye disease.

Authors:  Masashi Mimura; Yuko Nishikawa; Keiko Inagaki; Yohei Sato; Yasushi Fujita; Don O Kikkawa
Journal:  Taiwan J Ophthalmol       Date:  2022-02-28

4.  Early experience with teprotumumab for chronic thyroid eye disease.

Authors:  Daniel J Ozzello; Don O Kikkawa; Bobby S Korn
Journal:  Am J Ophthalmol Case Rep       Date:  2020-05-15

5.  Deep Lateral Wall Partial Rim-Sparing Orbital Decompression with Ultrasonic Bone Removal for Treatment of Thyroid-Related Orbitopathy.

Authors:  Álvaro Bengoa-González; Alicia Galindo-Ferreiro; Enrique Mencía-Gutiérrez; Hortensia Sánchez-Tocino; Agustín Martín-Clavijo; María-Dolores Lago-Llinás
Journal:  J Ophthalmol       Date:  2019-12-02       Impact factor: 1.909

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.